List of Excipients in API BETAMETHASONE DIPROPIONATE
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing BETAMETHASONE DIPROPIONATE
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Merck Sharp & Dohme Corp | DIPROLENE AF | betamethasone dipropionate | 0085-0517 | CARBOMER HOMOPOLYMER TYPE C | |
| Merck Sharp & Dohme Corp | DIPROLENE AF | betamethasone dipropionate | 0085-0517 | CETEARETH-30 | |
| Merck Sharp & Dohme Corp | DIPROLENE AF | betamethasone dipropionate | 0085-0517 | CHLOROCRESOL | |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Excipients in ANDA-approved (generic) drugs containing BETAMETHASONE DIPROPIONATE
| Company | Ingredient | NDC | Excipient |
|---|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | betamethasone dipropionate | 0168-0055 | CETOSTEARYL ALCOHOL |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | betamethasone dipropionate | 0168-0055 | CHLOROCRESOL |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | betamethasone dipropionate | 0168-0055 | MINERAL OIL |
| >Company | >Ingredient | >NDC | >Excipient |
Detailed excipient profiles for BETAMETHASONE DIPROPIONATE
Excipient focus: BUTYLATED HYDROXYTOLUENE
BETAMETHASONE DIPROPIONATE drug variants containing BUTYLATED HYDROXYTOLUENE
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | betamethasone dipropionate | 51672-1390 |
| Primus Pharmaceuticals Inc | betamethasone dipropionate | 68040-714 |
| Encore Dermatology Inc | betamethasone dipropionate | 69482-800 |
| >Company | >Ingredient | >NDC |
BETAMETHASONE DIPROPIONATE drug variants not containing BUTYLATED HYDROXYTOLUENE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0517 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0575 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0962 |
| >Company | >Ingredient | >NDC |
Excipient focus: CARBOMER HOMOPOLYMER TYPE B
BETAMETHASONE DIPROPIONATE drug variants containing CARBOMER HOMOPOLYMER TYPE B
| Company | Ingredient | NDC |
|---|---|---|
| Cosette Pharmaceuticals Inc | betamethasone dipropionate | 0713-0728 |
| Cosette Pharmaceuticals Inc | betamethasone dipropionate | 0713-0807 |
| Padagis Israel Pharmaceuticals Ltd | betamethasone dipropionate | 45802-021 |
| >Company | >Ingredient | >NDC |
BETAMETHASONE DIPROPIONATE drug variants not containing CARBOMER HOMOPOLYMER TYPE B
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0517 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0575 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0962 |
| >Company | >Ingredient | >NDC |
Excipient focus: CARBOMER HOMOPOLYMER TYPE C
BETAMETHASONE DIPROPIONATE drug variants containing CARBOMER HOMOPOLYMER TYPE C
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0517 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | betamethasone dipropionate | 0168-0265 |
| Padagis Israel Pharmaceuticals Ltd | betamethasone dipropionate | 45802-376 |
| >Company | >Ingredient | >NDC |
BETAMETHASONE DIPROPIONATE drug variants not containing CARBOMER HOMOPOLYMER TYPE C
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0575 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0962 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | betamethasone dipropionate | 0168-0055 |
| >Company | >Ingredient | >NDC |
Excipient focus: CETEARETH-30
BETAMETHASONE DIPROPIONATE drug variants containing CETEARETH-30
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0517 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | betamethasone dipropionate | 0168-0265 |
| Padagis Israel Pharmaceuticals Ltd | betamethasone dipropionate | 45802-376 |
| >Company | >Ingredient | >NDC |
BETAMETHASONE DIPROPIONATE drug variants not containing CETEARETH-30
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0575 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0962 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | betamethasone dipropionate | 0168-0055 |
| >Company | >Ingredient | >NDC |
Excipient focus: CETEARYL ALCOHOL
BETAMETHASONE DIPROPIONATE drug variants containing CETEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | betamethasone dipropionate | 50090-7525 |
| >Company | >Ingredient | >NDC |
BETAMETHASONE DIPROPIONATE drug variants not containing CETEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0517 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0575 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0962 |
| >Company | >Ingredient | >NDC |
Excipient focus: CETETH-20
BETAMETHASONE DIPROPIONATE drug variants containing CETETH-20
| Company | Ingredient | NDC |
|---|---|---|
| STAT RX USA LLC | betamethasone dipropionate | 16590-032 |
| Northstar Rx LLC | betamethasone dipropionate | 16714-996 |
| Rebel Distributors Corp | betamethasone dipropionate | 21695-521 |
| >Company | >Ingredient | >NDC |
BETAMETHASONE DIPROPIONATE drug variants not containing CETETH-20
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0517 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0575 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0962 |
| >Company | >Ingredient | >NDC |
Excipient focus: CETOSTEARYL ALCOHOL
BETAMETHASONE DIPROPIONATE drug variants containing CETOSTEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | betamethasone dipropionate | 0168-0055 |
| Actavis Pharma Inc | betamethasone dipropionate | 0472-0380 |
| STAT RX USA LLC | betamethasone dipropionate | 16590-032 |
| >Company | >Ingredient | >NDC |
BETAMETHASONE DIPROPIONATE drug variants not containing CETOSTEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0517 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0575 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0962 |
| >Company | >Ingredient | >NDC |
Excipient focus: CETYL ALCOHOL
BETAMETHASONE DIPROPIONATE drug variants containing CETYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Cosette Pharmaceuticals Inc | betamethasone dipropionate | 0713-0659 |
| Cosette Pharmaceuticals Inc | betamethasone dipropionate | 0713-0759 |
| A-S Medication Solutions | betamethasone dipropionate | 50090-5260 |
| >Company | >Ingredient | >NDC |
BETAMETHASONE DIPROPIONATE drug variants not containing CETYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0517 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0575 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0962 |
| >Company | >Ingredient | >NDC |
Excipient focus: CHLOROCRESOL
BETAMETHASONE DIPROPIONATE drug variants containing CHLOROCRESOL
BETAMETHASONE DIPROPIONATE drug variants not containing CHLOROCRESOL
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0575 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0962 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | betamethasone dipropionate | 0168-0267 |
| >Company | >Ingredient | >NDC |
Excipient focus: CYCLOMETHICONE
BETAMETHASONE DIPROPIONATE drug variants containing CYCLOMETHICONE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0517 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | betamethasone dipropionate | 0168-0265 |
| Padagis Israel Pharmaceuticals Ltd | betamethasone dipropionate | 45802-376 |
| >Company | >Ingredient | >NDC |
BETAMETHASONE DIPROPIONATE drug variants not containing CYCLOMETHICONE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0575 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0962 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | betamethasone dipropionate | 0168-0055 |
| >Company | >Ingredient | >NDC |
Excipient focus: CYCLOMETHICONE 5
BETAMETHASONE DIPROPIONATE drug variants containing CYCLOMETHICONE 5
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | betamethasone dipropionate | 50090-5232 |
| Taro Pharmaceuticals USA Inc | betamethasone dipropionate | 51672-1310 |
| RPK Pharmaceuticals Inc | betamethasone dipropionate | 53002-8281 |
| >Company | >Ingredient | >NDC |
BETAMETHASONE DIPROPIONATE drug variants not containing CYCLOMETHICONE 5
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0517 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0575 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0962 |
| >Company | >Ingredient | >NDC |
Excipient focus: DIAZOLIDINYL UREA
BETAMETHASONE DIPROPIONATE drug variants containing DIAZOLIDINYL UREA
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | betamethasone dipropionate | 51672-1390 |
| >Company | >Ingredient | >NDC |
BETAMETHASONE DIPROPIONATE drug variants not containing DIAZOLIDINYL UREA
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0517 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0575 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0962 |
| >Company | >Ingredient | >NDC |
Excipient focus: GLYCERYL OLEATE
BETAMETHASONE DIPROPIONATE drug variants containing GLYCERYL OLEATE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0517 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | betamethasone dipropionate | 0168-0265 |
| Padagis Israel Pharmaceuticals Ltd | betamethasone dipropionate | 45802-376 |
| >Company | >Ingredient | >NDC |
BETAMETHASONE DIPROPIONATE drug variants not containing GLYCERYL OLEATE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0575 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0962 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | betamethasone dipropionate | 0168-0055 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYETHYL CELLULOSE
BETAMETHASONE DIPROPIONATE drug variants containing HYDROXYETHYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | betamethasone dipropionate | 51672-1390 |
| Primus Pharmaceuticals Inc | betamethasone dipropionate | 68040-714 |
| Encore Dermatology Inc | betamethasone dipropionate | 69482-800 |
| >Company | >Ingredient | >NDC |
BETAMETHASONE DIPROPIONATE drug variants not containing HYDROXYETHYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0517 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0575 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0962 |
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
BETAMETHASONE DIPROPIONATE drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0962 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | betamethasone dipropionate | 0168-0267 |
| Taro Pharmaceuticals USA Inc | betamethasone dipropionate | 51672-1340 |
| >Company | >Ingredient | >NDC |
BETAMETHASONE DIPROPIONATE drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0517 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0575 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | betamethasone dipropionate | 0168-0055 |
| >Company | >Ingredient | >NDC |
Excipient focus: ISOPROPYL ALCOHOL
BETAMETHASONE DIPROPIONATE drug variants containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0962 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | betamethasone dipropionate | 0168-0267 |
| Cosette Pharmaceuticals Inc | betamethasone dipropionate | 0713-0728 |
| >Company | >Ingredient | >NDC |
BETAMETHASONE DIPROPIONATE drug variants not containing ISOPROPYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0517 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0575 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | betamethasone dipropionate | 0168-0055 |
| >Company | >Ingredient | >NDC |
Excipient focus: METHYLPARABEN
BETAMETHASONE DIPROPIONATE drug variants containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | betamethasone dipropionate | 51672-1390 |
| Primus Pharmaceuticals Inc | betamethasone dipropionate | 68040-714 |
| Encore Dermatology Inc | betamethasone dipropionate | 69482-800 |
| >Company | >Ingredient | >NDC |
BETAMETHASONE DIPROPIONATE drug variants not containing METHYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0517 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0575 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0962 |
| >Company | >Ingredient | >NDC |
Excipient focus: MINERAL OIL
BETAMETHASONE DIPROPIONATE drug variants containing MINERAL OIL
| Company | Ingredient | NDC |
|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | betamethasone dipropionate | 0168-0055 |
| Actavis Pharma Inc | betamethasone dipropionate | 0472-0380 |
| Actavis Pharma Inc | betamethasone dipropionate | 0472-0381 |
| >Company | >Ingredient | >NDC |
BETAMETHASONE DIPROPIONATE drug variants not containing MINERAL OIL
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0517 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0575 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0962 |
| >Company | >Ingredient | >NDC |
Excipient focus: OLEYL ALCOHOL
BETAMETHASONE DIPROPIONATE drug variants containing OLEYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | betamethasone dipropionate | 51672-1390 |
| Primus Pharmaceuticals Inc | betamethasone dipropionate | 68040-714 |
| Encore Dermatology Inc | betamethasone dipropionate | 69482-800 |
| >Company | >Ingredient | >NDC |
BETAMETHASONE DIPROPIONATE drug variants not containing OLEYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0517 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0575 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0962 |
| >Company | >Ingredient | >NDC |
Excipient focus: P-CHLORO-M-CRESOL
BETAMETHASONE DIPROPIONATE drug variants containing P-CHLORO-M-CRESOL
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | betamethasone dipropionate | 50090-7525 |
| >Company | >Ingredient | >NDC |
BETAMETHASONE DIPROPIONATE drug variants not containing P-CHLORO-M-CRESOL
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0517 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0575 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0962 |
| >Company | >Ingredient | >NDC |
Excipient focus: PETROLATUM
BETAMETHASONE DIPROPIONATE drug variants containing PETROLATUM
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0517 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0575 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | betamethasone dipropionate | 0168-0055 |
| >Company | >Ingredient | >NDC |
BETAMETHASONE DIPROPIONATE drug variants not containing PETROLATUM
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0962 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | betamethasone dipropionate | 0168-0267 |
| Cosette Pharmaceuticals Inc | betamethasone dipropionate | 0713-0728 |
| >Company | >Ingredient | >NDC |
Excipient focus: PHOSPHORIC ACID
BETAMETHASONE DIPROPIONATE drug variants containing PHOSPHORIC ACID
BETAMETHASONE DIPROPIONATE drug variants not containing PHOSPHORIC ACID
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0517 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0575 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | betamethasone dipropionate | 0168-0265 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYETHYLENE GLYCOL 1000
BETAMETHASONE DIPROPIONATE drug variants containing POLYETHYLENE GLYCOL 1000
| Company | Ingredient | NDC |
|---|---|---|
| A-S Medication Solutions | betamethasone dipropionate | 50090-1839 |
| A-S Medication Solutions | betamethasone dipropionate | 50090-2182 |
| REMEDYREPACK INC | betamethasone dipropionate | 70518-3884 |
| >Company | >Ingredient | >NDC |
BETAMETHASONE DIPROPIONATE drug variants not containing POLYETHYLENE GLYCOL 1000
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0517 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0575 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0962 |
| >Company | >Ingredient | >NDC |
Excipient focus: POLYOXYL 20 CETOSTEARYL ETHER
BETAMETHASONE DIPROPIONATE drug variants containing POLYOXYL 20 CETOSTEARYL ETHER
| Company | Ingredient | NDC |
|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | betamethasone dipropionate | 0168-0055 |
| Actavis Pharma Inc | betamethasone dipropionate | 0472-0380 |
| Cosette Pharmaceuticals Inc | betamethasone dipropionate | 0713-0659 |
| >Company | >Ingredient | >NDC |
BETAMETHASONE DIPROPIONATE drug variants not containing POLYOXYL 20 CETOSTEARYL ETHER
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0517 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0575 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0962 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL
BETAMETHASONE DIPROPIONATE drug variants containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0517 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0575 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0962 |
| >Company | >Ingredient | >NDC |
BETAMETHASONE DIPROPIONATE drug variants not containing PROPYLENE GLYCOL
| Company | Ingredient | NDC |
|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | betamethasone dipropionate | 0168-0055 |
| Actavis Pharma Inc | betamethasone dipropionate | 0472-0381 |
| Cosette Pharmaceuticals Inc | betamethasone dipropionate | 0713-0659 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL MONOPALMITOSTEARATE
BETAMETHASONE DIPROPIONATE drug variants containing PROPYLENE GLYCOL MONOPALMITOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0575 |
| Burel Pharmaceuticals LLC | betamethasone dipropionate | 35573-107 |
| A-S Medication Solutions | betamethasone dipropionate | 50090-6787 |
| >Company | >Ingredient | >NDC |
BETAMETHASONE DIPROPIONATE drug variants not containing PROPYLENE GLYCOL MONOPALMITOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0517 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0962 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | betamethasone dipropionate | 0168-0055 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL MONOSTEARATE
BETAMETHASONE DIPROPIONATE drug variants containing PROPYLENE GLYCOL MONOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | betamethasone dipropionate | 0168-0268 |
| A-S Medication Solutions | betamethasone dipropionate | 50090-7517 |
| Taro Pharmaceuticals USA Inc | betamethasone dipropionate | 51672-1317 |
| >Company | >Ingredient | >NDC |
BETAMETHASONE DIPROPIONATE drug variants not containing PROPYLENE GLYCOL MONOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0517 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0575 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0962 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLENE GLYCOL STEARATE
BETAMETHASONE DIPROPIONATE drug variants containing PROPYLENE GLYCOL STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Actavis Pharma Inc | betamethasone dipropionate | 0472-0382 |
| >Company | >Ingredient | >NDC |
BETAMETHASONE DIPROPIONATE drug variants not containing PROPYLENE GLYCOL STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0517 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0575 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0962 |
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYLPARABEN
BETAMETHASONE DIPROPIONATE drug variants containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | betamethasone dipropionate | 51672-1390 |
| Primus Pharmaceuticals Inc | betamethasone dipropionate | 68040-714 |
| Encore Dermatology Inc | betamethasone dipropionate | 69482-800 |
| >Company | >Ingredient | >NDC |
BETAMETHASONE DIPROPIONATE drug variants not containing PROPYLPARABEN
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0517 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0575 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0962 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM HYDROXIDE
BETAMETHASONE DIPROPIONATE drug variants containing SODIUM HYDROXIDE
BETAMETHASONE DIPROPIONATE drug variants not containing SODIUM HYDROXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0575 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0962 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | betamethasone dipropionate | 0168-0267 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, MONOBASIC
BETAMETHASONE DIPROPIONATE drug variants containing SODIUM PHOSPHATE, MONOBASIC
BETAMETHASONE DIPROPIONATE drug variants not containing SODIUM PHOSPHATE, MONOBASIC
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0517 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0575 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0962 |
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
BETAMETHASONE DIPROPIONATE drug variants containing SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0962 |
| STAT RX USA LLC | betamethasone dipropionate | 16590-032 |
| Rebel Distributors Corp | betamethasone dipropionate | 21695-521 |
| >Company | >Ingredient | >NDC |
BETAMETHASONE DIPROPIONATE drug variants not containing SODIUM PHOSPHATE, MONOBASIC, MONOHYDRATE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0517 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0575 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | betamethasone dipropionate | 0168-0055 |
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITAN MONOSTEARATE
BETAMETHASONE DIPROPIONATE drug variants containing SORBITAN MONOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Taro Pharmaceuticals USA Inc | betamethasone dipropionate | 51672-1390 |
| Primus Pharmaceuticals Inc | betamethasone dipropionate | 68040-714 |
| Encore Dermatology Inc | betamethasone dipropionate | 69482-800 |
| >Company | >Ingredient | >NDC |
BETAMETHASONE DIPROPIONATE drug variants not containing SORBITAN MONOSTEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0517 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0575 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0962 |
| >Company | >Ingredient | >NDC |
Excipient focus: SORBITOL
BETAMETHASONE DIPROPIONATE drug variants containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0517 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | betamethasone dipropionate | 0168-0265 |
| Padagis Israel Pharmaceuticals Ltd | betamethasone dipropionate | 45802-376 |
| >Company | >Ingredient | >NDC |
BETAMETHASONE DIPROPIONATE drug variants not containing SORBITOL
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0575 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0962 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | betamethasone dipropionate | 0168-0055 |
| >Company | >Ingredient | >NDC |
Excipient focus: STEARYL ALCOHOL
BETAMETHASONE DIPROPIONATE drug variants containing STEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Cosette Pharmaceuticals Inc | betamethasone dipropionate | 0713-0659 |
| Cosette Pharmaceuticals Inc | betamethasone dipropionate | 0713-0759 |
| A-S Medication Solutions | betamethasone dipropionate | 50090-5260 |
| >Company | >Ingredient | >NDC |
BETAMETHASONE DIPROPIONATE drug variants not containing STEARYL ALCOHOL
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0517 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0575 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0962 |
| >Company | >Ingredient | >NDC |
Excipient focus: WATER
BETAMETHASONE DIPROPIONATE drug variants containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0517 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0962 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | betamethasone dipropionate | 0168-0055 |
| >Company | >Ingredient | >NDC |
BETAMETHASONE DIPROPIONATE drug variants not containing WATER
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0575 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | betamethasone dipropionate | 0168-0268 |
| Actavis Pharma Inc | betamethasone dipropionate | 0472-0381 |
| >Company | >Ingredient | >NDC |
Excipient focus: WHITE PETROLATUM
BETAMETHASONE DIPROPIONATE drug variants containing WHITE PETROLATUM
| Company | Ingredient | NDC |
|---|---|---|
| Burel Pharmaceuticals LLC | betamethasone dipropionate | 35573-107 |
| Aurobindo Pharma Limited | betamethasone dipropionate | 59651-699 |
| >Company | >Ingredient | >NDC |
BETAMETHASONE DIPROPIONATE drug variants not containing WHITE PETROLATUM
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0517 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0575 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0962 |
| >Company | >Ingredient | >NDC |
Excipient focus: WHITE WAX
BETAMETHASONE DIPROPIONATE drug variants containing WHITE WAX
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0517 |
| Merck Sharp & Dohme Corp | betamethasone dipropionate | 0085-0575 |
| E Fougera & Co a division of Fougera Pharmaceuticals Inc | betamethasone dipropionate | 0168-0265 |
| >Company | >Ingredient | >NDC |
BETAMETHASONE DIPROPIONATE drug variants not containing WHITE WAX
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
